Categorical versus continuous circulating tumor cell enumeration as early surrogate marker for therapy response and prognosis during docetaxel therapy in metastatic prostate cancer patients

BACKGROUND: Circulating tumor cell (CTCs) counts might serve as early surrogate marker for treatment efficacy in metastatic castration-resistant prostate cancer (mCRPC) patients. We prospectively assessed categorical and continuous CTC-counts for their utility in early prediction of radiographic res...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:BMC Cancer
Main Authors: Thalgott, Mark, Rack, Brigitte, Eiber, Matthias, Souvatzoglou, Michael, Heck, Matthias M., Kronester, Caroline, Andergassen, Ulrich, Kehl, Victoria, Krause, Bernd J., Gschwend, Jurgen E., Retz, Margitta, Nawroth, Roman
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2015
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4459665/
https://ncbi.nlm.nih.gov/pubmed/26051431
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-015-1478-4
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares